Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Non-nutritive sweeteners exert no positive effect on BMI, adiposity

05 Aug 2017
We may need to be more skeptical of the benefits of artificial sweeteners

Non-nutritive sweeteners do not appear to clearly help in weight management and may even result in increased body mass index (BMI) and cardiometabolic risk, according to a new meta-analysis.

The meta-analysis involved 37 studies, of which 30 were cohort studies (n=405,907) and seven were randomized controlled trials (RCTs; n=1,003). According to the Cochrane Collaboration Risk of Bias tool, most of the RCTs had a high or unclear risk of bias. Most cohort studies had moderate quality according to the Newcastle-Ottawa scale.

Pooled data from three RCTs showed that intake of non-nutritive sweeteners had no positive effect on BMI over 6 to 24 months (mean difference [MD], -0.37 kg/m2; 95 percent CI, -1.10 to 0.36 kg/m2).

On the other hand, two cohort studies showed that continuous intake of non-nutritive sweeteners over 3 to 13 years resulted in weight gain in healthy individuals (n=21,256; mean correlation, 0.05; 0.03 to 0.06).

Five RCTs on the effects of non-nutritive sweeteners on obese participants showed no significant impact on weight (standardized MD [SMD], -0.17; -0.54 to 0.21). Moreover, two observational studies showed a positive correlation between non-nutritive sweetener intake and weight gain (n=32,504; weighted mean correlation, 0.06; 0.05 to 0.07).

Three RCTs showed that non-nutritive sweetener intake had an inconsistent effect on waist circumference (SMD, -0.16; -0.56 to 0.25), while a cohort study showed a positive correlation between the two (n=384; MD 2.27; 0.96 to 3.58).

The meta-analysis included RCTs and observational studies that assessed the effects of non-nutritive sweeteners on BMI, body weight and adiposity, among other outcomes. Only those with participants >12 years of age and that had a minimum duration of 6 months were included.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.